Bristol Stool Scale as a Determinant of Hepatic Encephalopathy Management in Patients With Cirrhosis

被引:12
|
作者
Duong, Nikki K. [1 ,2 ]
Shrestha, Shreesh [1 ,2 ]
Park, Dan [1 ,2 ]
Shahab, Omer [1 ,2 ]
Fagan, Andrew [1 ,2 ]
Malpaya, Zenaida [1 ,2 ]
Gallagher, Mary L. [1 ,2 ]
Morris, April [1 ,2 ]
Davis, Brian C. [1 ,2 ]
Bajaj, Jasmohan S. [1 ,2 ]
机构
[1] Virginia Commonwealth Univ, Richmond, VA 23284 USA
[2] Cent Virginia Vet Healthcare Syst, Richmond, VA 23249 USA
来源
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2022年 / 117卷 / 02期
关键词
FORM SCALE; LACTULOSE;
D O I
10.14309/ajg.0000000000001550
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
INTRODUCTION: Bowel movement (BM) frequency is used to titrate lactulose for hepatic encephalopathy (HE). However, stool consistency using the Bristol stool scale (BSS, 0-7) is often ignored. METHODS: The study included pre-BSS and post-BSS cohorts. BSS was incorporated into decision-making after training in outpatients with cirrhosis. Two to 3 BMs/d and BSS 3-4 were considered normal, whereas the rest were considered high or low; concordance between the metrics was evaluated. Medication changes and 6-month admissions were compared between this group (post-BSS) and a comparable previous group (pre-BSS). Concordance and regression analyses for all-cause admissions and H E-related admissions were performed, and comparisons were made for HE-related medication stability. In the longitudinal analysis, an outpatient group seen twice was analyzed for BSS and BMs. RESULTS: In the post-BSS cohort, 112 patients were included with only 46% BSS and BMs concordance and modest BSS/BMs correlation (r = 0.27, P = 0.005). Compared with a pre-BSS cohort (N = 114), there was a lower 6-month total (4% vs 0.36%, P< 0.001) or HE-related admission (1% vs 0.12%, P= 0.002). Regression showed model for end-stage liver disease (odds ratio [OR]: 1.10, P= 0.003) and pre-BSS/post-BSS (OR: 0.04, P< 0.001) for all-cause admissions and HE (OR: 3.59, P= 0.04) and preera/postera (OR: 0.16, P = 0.02) for HE-related admissions as significant. HE medication regimens were more stable post-BSS vs pre-BSS (32% vs 20%, P = 0.04), which was due to patients with BSS > BMs (P= 0.02). In the longitudinal analysis, 33 patients without medication changes or underlying clinical status changes were tested 36 +/- 24 days apart. No changes in BSS (P = 0.73) or BMs (P = 0.19) were found. DISCUSSION: BSS is complementary and additive to BM frequency, can modulate the risk of readmissions and stabilize HE-related therapy changes in outpatients with cirrhosis, and could help personalize HE management.
引用
收藏
页码:295 / 300
页数:6
相关论文
共 50 条
  • [31] Diabetes as a risk factor for hepatic encephalopathy in cirrhosis patients
    Jepsen, Peter
    Watson, Hugh
    Andersen, Per Kragh
    Vilstrup, Hendrik
    JOURNAL OF HEPATOLOGY, 2015, 63 (05) : 1133 - 1138
  • [32] Predictors of nonresponse to lactulose in patients with cirrhosis and hepatic encephalopathy
    Sharma, Praveen
    Sharma, Barjesh Chander
    Sarin, Shiv Kumar
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2010, 22 (05) : 526 - 531
  • [33] The incidence and outcome of postoperative hepatic encephalopathy in patients with cirrhosis
    Saleh, Zachary M.
    Solano, Quintin P.
    Louissaint, Jeremy
    Jepsen, Peter
    Tapper, Elliot B.
    UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2021, 9 (06) : 672 - 680
  • [34] Myosteatosis and sarcopenia are associated with hepatic encephalopathy in patients with cirrhosis
    Bhanji, Rahima A.
    Moctezuma-Velazquez, Carlos
    Duarte-Rojo, Andres
    Ebadi, Maryam
    Ghosh, Sunita
    Rose, Christopher
    Montano-Loza, Aldo J.
    HEPATOLOGY INTERNATIONAL, 2018, 12 (04) : 377 - 386
  • [35] Radiographical findings in patients with liver cirrhosis and hepatic encephalopathy
    Elwir, Saleh
    Hal, Hassan
    Veith, Joshua
    Schreibman, Ian
    Kadry, Zakiyah
    Riley, Thomas
    GASTROENTEROLOGY REPORT, 2016, 4 (03): : 221 - 225
  • [36] Barriers to Lactulose Adherence in Patients with Cirrhosis and Hepatic Encephalopathy
    Kenneth W. Chow
    Brittney M. Ibrahim
    Jung J. Yum
    An Dang
    Long Dang
    Kuan-Ting Chen
    Nicholas J. Jackson
    Sammy Saab
    Digestive Diseases and Sciences, 2023, 68 : 2389 - 2397
  • [37] Minimal hepatic encephalopathy and extrapyramidal signs in patients with cirrhosis
    Jover, R
    Compañy, L
    Gutiérrez, A
    Zapater, P
    Pérez-Serra, J
    Girona, E
    Aparicio, JR
    Pérez-Mateo, M
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2003, 98 (07): : 1599 - 1604
  • [38] Hepatic encephalopathy in patients with liver cirrhosis:: Is there a role of malnutrition?
    Kalaitzakis, Evangelos
    Bjornsson, Einar
    WORLD JOURNAL OF GASTROENTEROLOGY, 2008, 14 (21) : 3438 - 3439
  • [39] Hepatic Encephalopathy: Early Diagnosis in Pediatric Patients With Cirrhosis
    Dara, Naghi
    Sayyari, Ali-Akbar
    Imanzadeh, Farid
    IRANIAN JOURNAL OF CHILD NEUROLOGY, 2014, 8 (01) : 1 - 11
  • [40] Frequency of Minimal Hepatic Encephalopathy in Patients With Compensated Cirrhosis
    Zuberi, Bader Faiyaz
    Zohra, Fatima Tuz
    Alvi, Haris
    Alam, Muhammad Tanveer.
    Rasheed, Tazeen
    Nawaz, Zunaira
    Kumar, Pawan
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 : S861 - S862